Literature DB >> 30173659

Evaluating the Radioprotective Effect of Curcumin on Rat's Heart Tissues.

Sedighe Kolivand1, Peyman Amini2, Hana Saffar3, Saeed Rezapoor2, Elahe Motevaseli4, Masoud Najafi5, Farzad Nouruzi6, Dheyauldeen Shabeeb7,8, Ahmed Eleojo Musa7,8.   

Abstract

BACKGROUND: Heart injury is one of the most important concerns after exposure to a high dose of radiation in chest cancer radiotherapy or whole body exposure to a radiation disaster. Studies have proposed that increased level of inflammatory and pro-fibrotic cytokines following radiotherapy or radiation events play a key role in the development of several side effects such as cardiovascular disorders. In the current study, we aimed to evaluate the expression of IL-4 and IL-13 cytokines as well as signaling pathways such as IL4Ra1, IL13Ra2, Duox1 and Duox2. In addition, we detected the possible protective effect of curcumin on the expression of these factors and infiltration of inflammatory cells.
MATERIALS AND METHODS: Twenty rats were divided into 4 groups including control; curcumin treated; radiation; and radiation plus curcumin. After 10 weeks, rats were sacrificed for evaluation of mentioned parameters.
RESULTS: Results showed an increase in the level of IL-4 and all evaluated genes, as well as increased infiltration of lymphocytes and macrophages. Treatment with curcumin could attenuate these changes.
CONCLUSION: Curcumin could reduce radiation-induced heart injury markers in rats. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Duox1; Duox2; IL-13; IL-4; Radiation; curcumin; heart.

Mesh:

Substances:

Year:  2019        PMID: 30173659     DOI: 10.2174/1874471011666180831101459

Source DB:  PubMed          Journal:  Curr Radiopharm        ISSN: 1874-4710


  9 in total

Review 1.  Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents.

Authors:  Run Yang; Changming Tan; Masoud Najafi
Journal:  Inflammopharmacology       Date:  2021-11-23       Impact factor: 4.473

Review 2.  Cardiac Remodelling Following Cancer Therapy: A Review.

Authors:  Tan Panpan; Du Yuchen; Shi Xianyong; Liu Meng; He Ruijuan; Dong Ranran; Zhang Pengyan; Li Mingxi; Xie Rongrong
Journal:  Cardiovasc Toxicol       Date:  2022-07-25       Impact factor: 2.755

3.  Turmeric and Curcumin: From Traditional to Modern Medicine.

Authors:  Maryam Akaberi; Amirhossein Sahebkar; Seyed Ahmad Emami
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors.

Authors:  Ibrahim Y Abdelgawad; Kevin Agostinucci; Beshay N Zordoky
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2022-01-15       Impact factor: 5.187

Review 5.  Radiation-Induced Heart Diseases: Protective Effects of Natural Products.

Authors:  Ahmed Eleojo Musa; Dheyauldeen Shabeeb
Journal:  Medicina (Kaunas)       Date:  2019-05-09       Impact factor: 2.430

Review 6.  The Multifaced Actions of Curcumin in Pregnancy Outcome.

Authors:  Giovanni Tossetta; Sonia Fantone; Stefano Raffaele Giannubilo; Daniela Marzioni
Journal:  Antioxidants (Basel)       Date:  2021-01-17

Review 7.  Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers.

Authors:  Vasiliki Zoi; Vasiliki Galani; Pericles Tsekeris; Athanasios P Kyritsis; George A Alexiou
Journal:  Biomedicines       Date:  2022-01-28

8.  Metformin Protects Against Radiation-Induced Heart Injury and Attenuates the Upregulation of Dual Oxidase Genes Following Rat's Chest Irradiation.

Authors:  Rasoul Yahyapour; Peyman Amini; Hana Saffar; Saeed Rezapoor; Elahe Motevaseli; Mohsen Cheki; Bagher Farhood; Farzad Nouruzi; Dheyauldeen Shabeeb; Ahmed Eleojo Musa; Masoud Najafi
Journal:  Int J Mol Cell Med       Date:  2018-10-21

9.  Curcumin Protects Against Radiotherapy-Induced Oxidative Injury to the Skin.

Authors:  Dheyauldeen Shabeeb; Ahmed Eleojo Musa; Hayder Shabeeb Abd Ali; Masoud Najafi
Journal:  Drug Des Devel Ther       Date:  2020-08-05       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.